A review of respiratory medicines expenditure in the primary care reimbursement services: 2005-2015

Simple item page
dc.contributor.advisorMurphy, Aileenen
dc.contributor.authorO'Dwyer, Jackie
dc.contributor.otherIrish Asthma Society
dc.contributor.roleCivil Society Organizationen
dc.date.accessioned2019-10-25T11:08:52Z
dc.date.available2019-10-25T11:08:52Z
dc.date.issued2017-03-20
dc.description.abstractRespiratory disease, is part of the Governments chronic disease management policy. The aim is to manage chronic disease patients as close to their home for as long as possible. The economic benefit of this is to improve medicine adherence and avoid the cost of emergency hospital admissions. One adherence barrier is cost of medicines. The aim of this report was to gain clarity on respiratory medicines expenditure for an eleven year period from 2005-2015. Findings showed that expenditure on all medicines have been decreasing in recent years, with 2015 figures being less than expenditure in 2006. Respiratory medicines have been less than 10% of total medicines expenditure in the PCRS during this time. Drugs for OPD are the most frequently prescribed and highest expenditure medicine class. B2 stimulants are the most frequently prescribed drug group and B2 stimulants and corticoids have the highest expenditure.87% of drugs to treat OPD are dispensed publicly and 13% privately. A scenario analysis estimated that the extra cost to the State ranged between €20.2m to €33.8m, to provide respiratory medicines through public schemes, thus removing a barrier to adherence. By improving adherence rates the department is providing best outcomes and use of its finite resources.en
dc.description.statusNot peer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationO’Dwyer, J. (2017) A review of respiratory medicines expenditure in the primary care reimbursement services: 2005-2015. Cork: Community-Academic Research Links, University College Cork.en
dc.identifier.endpage42en
dc.identifier.urihttps://hdl.handle.net/10468/8860
dc.language.isoenen
dc.publisherCommunity-Academic Research Links, University College Corken
dc.relation.ispartofseriesCARL Research Reports;54
dc.relation.urihttps://www.ucc.ie/en/scishop/rr/
dc.rights©2017, Jackie O’Dwyer.en
dc.subjectRespiratory medicines expenditureen
dc.subjectPrimary careen
dc.subjectReimbursement servicesen
dc.subjectRespiratory diseaseen
dc.subjectChronic disease management policyen
dc.subjectCost of emergency hospital admissionsen
dc.subjectExpenditure on medicinesen
dc.titleA review of respiratory medicines expenditure in the primary care reimbursement services: 2005-2015en
dc.typeReporten
dc.type.qualificationnameMA Health Economics Practiceen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
JackieODwyerCARLreport2017IrishAsthmaSociety.pdf
Size:
847.92 KB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
CARL Research Reports 2017